Market Overview

The Global Zika Virus Testing Market was valued at USD 271.6 million in 2023 and is expected to reach USD 499.0 million by 2031 while growing at a CAGR of 7.9% during the forecast period (2024-2031).

*Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report

Market Dynamics

This section of the report will analyze various driving and restraining factors that are expected to have a significant impact on the global zika virus testing market growth. Zika virus testing detects the virus in potentially infected individuals. It spreads through Aedes mosquitoes, as well as via sexual contact, blood transfusion, and from mother to fetus. Symptoms range from mild, like fever and rash, to severe complications such as microcephaly in babies and Guillain-Barré syndrome.

Continuous innovation in diagnostic technologies, such as molecular assays, serological tests, and rapid point-of-care tests, along with cost constraints, are key drivers of the Zika virus testing market. However, these cost constraints and diagnostic algorithm challenges could potentially hinder market growth.

Furthermore, the global zika virus testing industry will be analyzed through various tools including PESTLE analysis, and Porter’s analysis.

Segmentation – By Test Type Analysis

The Global Zika Virus Testing Market is segmented among Molecular Test, and Serologic Test, based on Test Type. In 2023, Molecular Test accounted for the majority of the market share*.

*Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report

Segmentation – By End User Analysis

The Global Zika Virus Testing Market is segmented among Hospital/Clinic, Diagnostics Laboratory, and Others, based on Type. In 2023, Hospital/Clinic accounted for the majority of the market share*.

*Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report

Global Zika Virus Testing Market: Regional Analysis

Based on region, the market is divided into six regions including North America, Europe, Asia Pacific, Latin America, Middle East, and Africa. In 2023, North America dominated the market with the highest market share, while Asia Pacific is expected to grow with the highest CAGR during the forecast period (2024 – 2031).

*Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report

Competitive Landscape

Some of the key players operating in the market are Abbott, altona Diagnostics GmbH, Chembio Diagnostics, Inc., ELITechGroup, F. Hoffmann-La Roche Ltd, Genekam, DiaSorin (Luminex Corporation), Novacyt Group, Quest Diagnostics, and Siemens Healthcare GmbH

Table of Contents:

1. Research Methodology and Market Scope

• Research Methodology

• Market Scope

2. Executive Summary

3. Global Zika Virus Testing Market Dynamics

• Drivers

• Restraints

• Opportunity

4. Global Zika Virus Testing Industry Analysis

• PEST Analysis

• Porter's Five Force Analysis

• Recent Deals Analysis

5. Global Zika Virus Testing Market Segmentation, By Test Type

• Global Zika Virus Testing Market Share Analysis, By Test Type

• Global Zika Virus Testing Market Growth Analysis, By Test Type

• Global Zika Virus Testing Market Trends, By Test Type

o Molecular Test

o Serologic Test

6. Global Zika Virus Testing Market Segmentation, By End User

• Global Zika Virus Testing Market Share Analysis, By End User

• Global Zika Virus Testing Market Growth Analysis, By End User

• Global Zika Virus Testing Market Trends, By End User

o Hospital/Clinic

o Diagnostics Laboratory

o Others

7. Global Zika Virus Testing Market Segmentation, By Region

• Global Zika Virus Testing Market Share Analysis, By Region

• Global Zika Virus Testing Market Growth Analysis, By Region

• Global Zika Virus Testing Market Trends, By Region

o North America

o Europe

o Asia Pacific

o Latin America

o Middle East

o Africa

8. Competitive Landscape

• Abbott*

o Company Overview

o Financial Performance

o Key Development/Strategies

o SWOT Analysis

• altona Diagnostics GmbH

• Chembio Diagnostics, Inc.

• ELITechGroup

• F. Hoffmann-La Roche Ltd

• Genekam

• DiaSorin (Luminex Corporation)

• Novacyt Group

• Quest Diagnostics

• Siemens Healthcare GmbH

*Similar analysis will be provided for each company listed above.